Vimarsana
Biggest News Aggregation in the World

Marisol Quintero News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marisol Quintero. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marisol Quintero Today - Breaking & Trending Today

Report: Paso Robles Chili's location closes after 16 years - Paso Robles Daily News - Vimarsana News

Report: Paso Robles Chili's location closes after 16 years - Paso Robles Daily News

Location was the last Chili’s in San Luis Obispo County – San Luis Obispo County bid farewell to its final Chili’s Grill & Bar restaurant […]

No more Chili's baby back ribs in SLO County as chain closes its last restaurant here - Vimarsana News

No more Chili's baby back ribs in SLO County as chain closes its last restaurant here

The restaurant shut its doors for good on Tuesday.

Source: yahoo.com
Highlight Therapeutics to present at the American Association for Cancer Research (AACR) Annual Meeting 2022 - Vimarsana News

Highlight Therapeutics to present at the American Association for Cancer Research (AACR) Annual Meeting 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Highlight Therapeutics Presenting at the Proactive One2One Virtual Forum - Vimarsana News

Highlight Therapeutics Presenting at the Proactive One2One Virtual Forum

Highlight Therapeutics Presenting at the Proactive One2One Virtual Forum - October 2021

Highlight & Pivotal start Phase IIa melanoma trial - Vimarsana News

Highlight & Pivotal start Phase IIa melanoma trial

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Highlight & Pivotal start Phase IIa melanoma trial Highlight TherapeuticsMarch 2, 2021 GMT Highlight Therapeutics and Pivotal work together on Melanoma therapy and launch a Phase IIa trial to examine BO-112 efficacy and safety Trial will examine administration of Highlight’s BO-112 in combination with an anti-PD1 in unresectable or metastatic melanoma patients Recruitment has already begun across 19 top-level centers in Spain and France No delays to recruitment despite the persistent challenges ...

Source: apnews.com